Spores for prevention of recurrent C difficile infection; 2 studies of newer antivirals for HCV; and more. | Learning | The JAMA Network
[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Sign in or Create an Account to track your personal CME/MOC activities
0 Credit Audio 7 min 48 sec JAMA May 5, 2015

Spores for prevention of recurrent C difficile infection; 2 studies of newer antivirals for HCV; and more.

×